JAX receives $1M from the Mark Foundation for Cancer Research

Funds will support research into immunotherapy response rates and side effects

Immunotherapy can be a crucial tool for patients undergoing cancer treatment, vastly improving outcomes for many whose conditions would otherwise be fatal. Unfortunately a subset of these patients develop toxic autoimmune side effects to immune checkpoint inhibitor (ICI) treatment. If we could predict those individuals at risk of developing particular adverse events, interventions for such complications could be initiated in the timeliest fashion.

A new $1 million grant from the Mark Foundation for Cancer Research presented to The Jackson Laboratory will fund research to study why these side effects sometimes occur and use the power of genetics to predict better outcomes for patients. Read more

Related Posts

Portland startup Marin Skincare launches lobster-based lip treatment

Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments.  Founded¬†out of the University...

20 November 2023

UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River

University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...

16 November 2023

FocusMaine co-founder named group’s next president

Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...

15 November 2023